Table 1. Model inputs for TB treatment outcomes, by treatment phase.
Outcome | Treatment phase | Reference(s) | ||||
Week 0–2 | Week 3–8 | Month 3–4 | Month 5–6 | Total | ||
Duration | 2 weeks | 6 weeks | 2 months | 2 months | 2 weeks-6 months | |
Percentage defaulting (sensitivity analysis range) | 0.2% (0–1.0%) | 1.9% (0–4.1%) | 2.7% (0–5.7%) | 2.2% (0–4.8%) | 7.0% (2–15%) | [1],[6] |
Percentage dying (sensitivity analysis range) | 1.1% (0.5–2.1%) | 1.3% (0.6–2.5%) | 0.8% (0.4–1.7%) | 0.8% (0.4–1.7%) | 4.0% | [1],[28]–[30] |
Percentage completing treatment period | 98.7% | 96.8% | 96.5% | 96.9% | - | |
Cumulative percentage remaining in therapy | 98.7% | 95.0% | 92.1% | 89.0% | 89.0% |